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Overproduction of -amyloid (A) is a pathologic feature of Alzheimer’s disease, leading to cognitive impairment. Here, we investigated
the impact of cell-specific receptor for advanced glycation end products (RAGE) on A-induced entorhinal cortex (EC) synaptic dysfunc-
tion. We found both a transient depression of basal synaptic transmission and inhibition of long-term depression (LTD) after the
application of A in EC slices. Synaptic depression and LTD impairment induced by A were rescued by functional suppression of RAGE.
Remarkably, the rescue was only observed in slices from mice expressing a defective form of RAGE targeted to microglia, but not in slices
from mice expressing defective RAGE targeted to neurons. Moreover, we found that the inflammatory cytokine IL-1 (interleukin-1)
and stress-activated kinases [p38 MAPK (p38 mitogen-activated protein kinase) and JNK (c-Jun N-terminal kinase)] were significantly
altered and involved in RAGE signaling pathways depending on RAGE expression in neuron or microglia. These findings suggest a
prominent role of microglial RAGE signaling in A-induced EC synaptic dysfunction.
Introduction
A characteristic feature of Alzheimer’s disease (AD) is the pres-
ence of -amyloid (A) deposits to form senile plaques. Animal
models of AD revealed that synaptic and behavioral deficits ap-
pear earlier than histopathological signs of neurodegeneration
(Chapman et al., 1999; Hsia et al., 1999; Li et al., 1999; Oddo et al.,
2003; Ingelsson et al., 2004). This discrepancy has been ascribed
to the presence of soluble oligomeric species of A inducing the
development of neuronal dysfunction. Synthetic or naturally
produced oligomeric A or oligomeric A extracts from cerebral
cortex of AD patients are capable of inhibiting hippocampal
long-term potentiation (LTP) (Lambert et al., 1998; Chen et al.,
2002; Vitolo et al., 2002; Walsh et al., 2002, Wang et al., 2004;
Shankar et al., 2008). A few reports have also shown that admin-
istration of A at low micromolar concentrations reduces hip-
pocampal long-term depression (LTD) (Hsieh et al., 2006) [but
see Kim et al., 2001; Shankar et al., 2008; Li et al., 2009 (in which
A was shown to facilitate LTD induction); or Wang et al., 2002,
2004; Raymond et al., 2003 (in which A did not affect LTD)].
Furthermore, low micromolar concentrations of A have been
shown to induce synaptic depression by regulating glutamate
receptors trafficking (Snyder et al., 2005; Tyszkiewicz and Yan,
2005; Hsieh et al., 2006), whereas lower nanomolar concentra-
tions did not affect basal synaptic transmission (Lambert et al.,
1998; Vitolo et al., 2002; Walsh et al., 2002). In agreement with
these results, animal models of AD characterized by progressive
accumulation of A showed that LTP disruption occurs before
deficits in basal synaptic transmission and LTD (Trinchese et al.,
2004; Chang et al., 2006). Thus, progression of synaptic dysfunc-
tion by A is likely to be concentration dependent, possibly cor-
responding to progressive cognitive decline induced by its
accumulation during the course of AD. These studies raise the
question of whether the interaction of cell surface receptors with
oligomeric A contributes to aberrant synaptic function.
The receptor for advanced glycation end products (RAGE)
functions as a cell surface binding site for A in different cells
(neurons, glia, endothelial cells) (Yan et al., 1995; Hofmann et al.,
1999; Lue et al., 2001; Schmidt et al., 2001; Deane et al., 2003; Lue
et al., 2005; Chen et al., 2007). Furthermore, the introduction of a
wild-type RAGE transgene targeted to neurons in the AD-type
transgenic mouse model expressing mAPP (mutant human amy-
loid precursor protein) accelerated A-mediated neuronal per-
turbation (Arancio et al., 2004). As previously demonstrated by
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our groups, specific activation of neuronal RAGE was involved in
synaptic dysfunction induced by nanomolar A in the entorhinal
cortex (Origlia et al., 2008). In addition, the activation of RAGE
in microglia enhances production of proinflammatory media-
tors, such as interleukin-1 (IL-1) and tumor necrosis factor-
(TNF-) (Lue et al., 2001) (for review, see Simm et al., 2004;
Chen et al., 2007; Fang et al., 2010). This evidence led us to ad-
dress the question of whether synaptic dysfunction, including
progressive synaptic impairment by A load, depends on cell-
specific activation of RAGE, such as neuronal RAGE versus mi-
croglial RAGE. In the present study, we investigated the impact of
microglial RAGE-dependent signaling on A-induced synaptic
dysfunction. The study was conducted in the entorhinal cortex
(EC), a brain area involved in learning/memory and contributing
to cognitive decline at early stages of AD (Braak and Braak, 1991).
To achieve our aim, we used new transgenic mice expressing
a dominant-negative form of RAGE targeted to microglia
(DNMSR) or targeted to neurons (DN-RAGE). We present ex-
perimental evidence that synaptic depression and LTD impair-
ment induced by A are dependent on microglial RAGE.
Moreover, we show that the inflammatory cytokine IL-1 and
stress-activated kinase [p38 mitogen-activated protein kinase
(p38 MAPK) and c-Jun N-terminal kinase (JNK)] phosphor-
ylation is altered and differently involved in RAGE signaling
pathways.
Materials and Methods
Homozygous RAGE-null, transgenic DN-RAGE, and DNMSR mice.
Homozygous RAGE-null mice were generated and characterized as de-
scribed previously (Sakaguchi et al., 2003; Wendt et al., 2003). Homozy-
gous RAGE-null mice were backcrossed for 10 generations into the
C57BL/6 background. In addition, we used transgenic mice with signal
transduction-deficient mutants of RAGE in which the cytosolic domain
of the receptor has been deleted, thereby imparting a dominant-negative
RAGE effect, targeted to neurons (DN-RAGE, driven by the platelet-
derived growth factor-B chain promoter) or to microglia (DNMSR,
driven by the macrophage scavenger receptor promoter). The PDGF-B
chain promoter has been successfully used to drive expression of trans-
gene targeted to neurons (Sasahara et al., 1991; Mucke et al., 2000; Lust-
bader et al., 2004; Takuma et al., 2005). Furthermore, transgenic mice
expressing neuronal DN-RAGE driven by the PDGF-B chain promoter
have been previously characterized, demonstrating localization of DN-
RAGE in cortical neurons (Arancio et al., 2004). Transgenic mice ex-
pressing DN-RAGE in microglia under the macrophage scavenger
receptor (MSR) promoter, originally provided by Dr. S. F. Yan (Colum-
bia University, New York, NY), have been used in our previous study
(Fang et al., 2010). Male transgenic mice and their littermate controls
were used for the in vitro electrophysiology (age range, 2–3 months).
Pharmacologic agents. A(1-42) and the reversed peptide A(42-1)
were purchased from BioSource. Oligomeric A(1-42) peptide was pre-
pared as described previously and characterized by atomic force micros-
copy (Yan et al., 2007) and mass spectrometry as reported by Origlia et al.
(2009). Aliquots were stored at 20°C in DMSO as a 200 mM stock solution
and diluted to the desired final concentration in artificial CSF (ACSF)
[containing the following (in mM): 119 NaCl, 2.5 KCl, 2 CaCl2, 1.2
MgSO4, 1 NaH2PO4, 26.2 NaHCO3, 11 glucose], immediately before
application (Simmons et al., 1994). 4-(4-Fluorophenyl)-2-(4-metyl-
sulfinylphenyl)-5-(4-pyridyl)-1 H-imidazole (SB203580) and anthra(1-
9-cd)pyrazol-6(2 H)-one (SP600125) were purchased from Alexis and
prepared in DMSO stock solutions. IL-1, interleukin-1 receptor antag-
onist (IL-1Ra), and TNF- were purchased from PeproTech. These
drugs were also diluted to the desired final concentration in ACSF. Spe-
cific antibodies to RAGE have been described in our previous studies
(Yan et al., 1996).
Slice preparation. Animals were deeply anesthetized using urethane
(20% solution, 1 ml/100 g body weight) via intraperitoneal injection and
then decapitated after disappearance of the tail pinch reflex. The brain
was rapidly removed and thick horizontal sections (400 m), containing
the entorhinal area, were made on a Vibratome. All steps were performed
in ice-cold ACSF solution bubbled with 95% O2/5% CO2. Before record-
ing, slices were stored for at least 1 h in a recovery chamber containing
oxygenated ACSF solution at room temperature. During electrophysio-
logical recordings, slices were perfused at a rate of 2.5–3 ml/min with
oxygenated ACSF at 33  1°C.
Electrophysiological recordings. Extracellular field potentials (FPs) were
evoked in layer III in response to electrical stimulation of layer II (Origlia
et al., 2008). The amplitude of the FPs was used as a measure of the
evoked population excitatory current (Domenici et al., 1995; Pesavento
et al., 2002). All FPs had peak latency between 4.5 and 6 ms. Baseline
responses were obtained with a stimulation intensity that yielded 50 –
60% of maximal amplitude. FP amplitude was monitored every 20 s and
averaged every three responses by online data acquisition software
(Anderson and Collingridge, 2001). After 15 min of stable baseline re-
cording, low-frequency stimulation (LFS) (900 paired pulses at 1 Hz, the
interval between paired pulses was 30 ms) (Kourrich and Chapman,
2003) was used to induce LTD and its magnitude was measured as the
average of FP amplitudes between the 30th and the 40th minute after
termination of induction protocol. Values were expressed as mean 
SEM percentage change relative to their mean baseline amplitude. A
peptides were applied by general perfusion for 10 min, unless otherwise
stated. The effect of A on basal synaptic transmission was calculated as
the average of FPs amplitude recorded during the last 3 min of A per-
fusion. In experiments using the p38 MAPK inhibitor (SB203580) or
JNK inhibitor (SP600125), compounds were continuously perfused over
slices (Origlia et al., 2008), starting at least 30 min before LFS. For patch-
clamp experiments, 350 m horizontal slices containing EC were cut
with a vibratome and maintained as described above. Patch pipettes (4 – 6
M) were pulled from thick-walled borosilicate glass tubing and filled
with a solution containing the following: 117.5 mM Cs-methylsulfonate,
17.5 mM CsCl2, 4 mM NaCl, 0.1 mM EGTA, 10 mM HEPES, 5 mM QX-
314Cl [N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium
chloride] (Tocris), 4 mM MgATP, 0.3 mM Na2GTP, 10 mM phospho-
creatine-Tris, pH adjusted to 7.3 with CsOH, osmolarity adjusted to 290
mOsm with sucrose. Currents were recorded with a PC-501A amplifier
(Warner Instruments) and filtered at 1 kHz (holding potential, 70
mV). The input resistance was determined from the current at the end of
a 3 mV, 10 ms hyperpolarization voltage step. To eliminate artifacts
caused by variation of the seal properties, the access resistance was mon-
itored for constancy throughout all experiments. Synaptic input was
evoked by layer II/III stimulation using concentric bipolar electrodes.
Ten minutes of stable access resistance were required before beginning
measurements of the EPSC amplitude. The amplitude was measured
automatically by using the Clampfit program (version 10.2) from Mo-
lecular Devices. For the I–V experiments, 3 M bicuculline and 1 M
CGP55845[(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydro-
xypropyl](phenylmethyl)phosphinic acid hydrochloride] (Tocris), to
block GABAA and GABAB receptors, were added to the bath. To isolate
the synaptic currents, membrane currents recorded at each membrane
potential in the absence of stimulation were subtracted from the evoked
synaptic responses. The AMPA receptor and NMDA receptor currents
were calculated as the peak response at 70 mV and the current mea-
sured 50 ms after the peak at 50 mV, respectively. At the end of all
experiments, specific AMPA receptor antagonist NBQX (2,3-dioxo-6-nitro-
1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide) (10 M) and
NMDA receptor antagonist AP5 (50 M) were added to confirm the correct
isolation of AMPA and NMDA currents. For miniature EPSCs (mEPSCs) in
the intracellular solution, Cs-methylsulfonate and CsCl2 were substituted
with K-gluconate and KCl. mEPSCs were recorded at 60 mV in the pres-
ence of 1 M tetrodotoxin and 3 M bicuculline and analyzed using Mini
Analysis Program (Synaptosoft) considering currents 5 pA.
ELISAs. Quantification of phosphorylated [pTpY180/182]p38 MAPK
or phosphorylated [pTpY183/185]JNK were detected in protein extracts
from slices collected after electrophysiology using two different ELISA
kits (BioSource); levels of phosphorylated forms were normalized with
respect to the total p38 MAPK and total JNK protein content that was
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assessed using two ELISA kits purchased from the same company (Bio-
Source). Quantification of IL-1 and TNF- was performed using ELISA
kits purchased from Bender Medsystem. After electrophysiology, slices
were collected, immediately frozen at 80°C, and subsequently lysed in
cell extraction buffer (10 mM Tris, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1
mM EGTA, 1 mM NaF, 20 mM Na4P2O7, 2 mM Na3VO4, 1% Triton X-100,
10% glycerol, 0.1% SDS, 0.5% deoxycholate, and 1 mM PMSF; Sigma-
Aldrich protease mixture inhibitor). The extract was then centrifuged
(13,000 rpm, 10 min at 4°C) to obtain a clear lysate that was used for the
assay.
Statistical analysis. All data are reported as mean  SEM. Statistical
comparisons between experimental groups or between FP amplitudes
measured during baseline and after the induction protocol were per-
formed by applying two-way repeated-measures ANOVA with pairwise
multiple-comparison procedures (Holm–Sidak method). Compari-
sons between different groups in ELISA experiments were performed
using one-way ANOVA. Differences were considered significant
when p  0.05.
Results
Micromolar A causes synaptic depression and LTD
impairment in entorhinal cortex
Several lines of evidence show a progressive impairment of syn-
aptic function with increasing A concentrations. In particular,
synthetic oligomeric A(1-42) in the nanomolar range was
shown to inhibit LTP leaving unaffected synaptic transmission
(for EC, see Origlia et al., 2008; for hippocampus, see Vitolo et al.,
2002). Higher micromolar concentrations caused synaptic de-
pression and LTD reduction in hippocampus (Snyder et al., 2005;
Hsieh et al., 2006; Parameshwaran et al., 2007). These studies
prompted us to investigate the effect of synthetic oligomeric
A(1-42) on basal synaptic transmission and LFS-induced LTD
in EC. This A preparation was previously characterized (Origlia
et al., 2009) and showed the presence of monomers, dimers, and
trimers (Yan et al., 2007). We focused our studies on the EC, an
area of the brain connected both to the hippocampus and asso-
ciative cortical areas, and crucially involved in cognitive func-
tions (Witter et al., 1989). In addition, this brain area is affected at
an early stage of AD (Braak and Braak, 1991). In horizontal slices
of EC, we recorded FPs from superficial cortical layer II/III after
stimulation of layer II, as described by Origlia et al. (2008). Bath
application of 1 M A for 10 min caused a significant decrease of
FP amplitude with respect to vehicle and A(42-1)-treated slices
(83  2%, n  11, vs 103  2%, n  7, and 101  2%, n  6; p 
0.05) (Fig. 1A). A-induced synaptic depression was transient
and FP amplitude returned to baseline values after washout (Fig.
1A). We also investigated whether 1 M A was able to affect
LTD, a long-term form of synaptic plasticity that can be reliably
induced in EC through a LFS protocol (900 paired pulses at 1 Hz,
30 ms interstimulus interval) (Origlia et al., 2008). LFS induced
stable LTD (Fig. 1B) in vehicle-treated slices (mean FP amplitude
was 80  6%; n  11; p  0.05 vs baseline). As previously dem-
onstrated (Kourrich and Chapman, 2003), LTD was NMDA de-
pendent because it was blocked by the NMDA receptor blocker
AP5 (50 M) (Fig. 1B) (mean FP amplitude was 99  3%; p 
0.38 vs baseline). This form of LTD was not saturated after the
first LFS and additional depression was induced using a second
LFS stimulation (supplemental Fig. S1A, available at www.
jneurosci.org as supplemental material). Bath perfusion of A (1
M) starting before LFS stimulation inhibited LTD expression
(Fig. 1C), when applied for a short period (mean amplitude 40
min after LFS was 78  7%; n  7; p  0.05 vs FP amplitude
during A perfusion). To rule out the possibility that A effect
was already vanished by the time of LFS application, we pro-
longed the period of A perfusion throughout the LFS stimula-
tion (40 min). Also in this case (Fig. 1D), LTD was blocked (mean
amplitude 40 min after LFS was 84  5%; p  0.05 vs 81  4%
during A perfusion; n  8). Interestingly, A effect was revers-
ible and LTD normally expressed when LFS was applied after A
washout (Fig. 1E) (mean LTD was 78  7%; n  8; p  0.05 vs
baseline). Furthermore, A-induced depression was not oc-
cluded by LFS as shown in Figure 1F (mean amplitude was 66 
5% during A perfusion; p  0.05 vs 78  5% after LFS; n  10).
Together, these results suggest that micromolar A induces tran-
sient synaptic depression and inhibition of LFS-LTD.
Since A synaptic depression has been linked to reduction of
AMPA or NMDA currents (Snyder et al., 2005; Hsieh et al., 2006;
Parameshwaran et al., 2007), we next sought to determine the
effect of 10 min 1 M A(1-42) on AMPA- and NMDA-receptor
mediated currents in layer II/III pyramidal neurons of EC. First,
we recorded spontaneous mEPSCs in the presence of tetrodo-
toxin (TTX) and bicuculline. The mean amplitude of mEPSCs
(Fig. 2B), but not the frequency (Fig. 2C), was affected by the
treatment with 1 M A for 10 min (mean amplitude was 9  0.7
pA, n  7, vs 14.4  0.6 pA in vehicle-treated cells, n  13; p 
0.05). After washing out A (Fig. 2A,B), the amplitude of
mEPSCs returned to control values. We then assessed AMPA and
NMDA EPSCs and their relative current–voltage ( I–V) relation-
ships before and after perfusion of the slices with 1 M A for 10
min. A caused a significant reduction of AMPA-mediated EPSC
peak amplitude (Fig. 2D,E) (mean amplitude recorded at 70
mV was 77  1% of baseline; n  10; p  0.05 vs 99  2% in
vehicle-treated slices and 96  3% during washout), but did not
significantly affect NMDA currents (Fig. 2D,F). Our results are
in agreement with previous findings (Hsieh et al., 2006; Shemer et
al., 2006; Parameshwaran et al., 2007), suggesting an involvement
of AMPA receptor-mediated current in A-dependent alteration
of synaptic transmission (see also supplemental Fig. S1B,C, avail-
able at www.jneurosci.org as supplemental material, showing
that A induced depression is not affected by perfusion with the
NMDA receptor blocker AP5). Thus, 1 M A not only impairs
LFS-LTD in EC but also induces a reduction in FP amplitude
associated with reduction of spontaneous AMPA mEPSC ampli-
tude and evoked AMPA EPSC amplitude.
Microglial RAGE contributes to A-dependent synaptic
depression and LTD impairment
RAGE is a key receptor, mediating A-induced synaptic plasticity
impairment in the hippocampus (Arancio et al., 2004) and in
cortical areas (Origlia et al., 2008, 2009). In particular, function-
less RAGE in neurons was able to abolish 200 nM A inhibition of
LTP (Origlia et al., 2008). To test whether RAGE was involved in
1 M A-induced depression and LTD inhibition, we first exam-
ined the effect of 10 min application of A(1-42) in EC slices
from RAGE-null mice and in slices from WT mice pretreated
with anti-RAGE IgG (2.5 g/ml in ACSF). As previously re-
ported, RAGE deficiency does not affect basal synaptic transmis-
sion and LTD expression in EC slices (Origlia et al., 2008). As
shown in Figure 3A, blockade of RAGE by either knocking out
RAGE gene or neutralizing anti-RAGE IgG was able to prevent
A-dependent synaptic depression. The mean FP amplitude in
RAGE-null mice (97  2%; n  5) and anti-RAGE IgG (99  2%;
n  5)-treated slices did not significantly change during A per-
fusion and was significantly different from WT slices treated with
A alone (83  2%; n  11; p  0.05). These results confirmed
that RAGE contributes to amyloid-induced synaptic dysfunc-
tion. RAGE is expressed in neurons as well as in other non-
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neuronal cells (glial cells, endothelial cells) (Schmidt et al., 2001;
Lue et al., 2005, Chen et al., 2007). Thus, we analyzed the contri-
bution of RAGE expressed in different cell types, such as in neu-
rons and microglia, to A-induced synaptic depression. To
investigate this issue, we used EC slices obtained from mice over-
expressing a dominant-negative form of RAGE targeted to neu-
rons (DN-RAGE) and to microglia (DNMSR). Remarkably,
deficiency of RAGE in neurons (DN-RAGE) (Fig. 3B) was not
sufficient to prevent A synaptic depression (76  5%; n  6; p 
0.05 vs vehicle-treated slices); in contrast, A failed to induce
synaptic depression in DNMSR slices (98  1%; n  6; p  0.05
vs vehicle-treated slices). In addition, both a complete deficiency
of RAGE (RAGE-null slices or anti-RAGE
IgG-treated slices) and a selective inacti-
vation of RAGE in microglia (DNMSR)
were able to prevent A-dependent LTD
inhibition (Fig. 3C–E) using bath applica-
tion of 1 M A for 10 min; similar results
were obtained with prolonged application
of 1 M A for 40 min (anti-RAGE IgG,
n  4; DNMSR, n  5) (data not shown).
After 1 M A treatment, LTD induced by
LFS in RAGE-null (74  8%; n  5), anti-
RAGE IgG (73  9%; n  5), and DNMSR
slices (80  7%; n  7) was comparable
with controls ( p  0.05 vs 80  6%; n 
11 in vehicle-treated slices) (Fig. 1) or to
DNMSR slices without A (supplemental
Fig. S2A, available at www.jneurosci.org
as supplemental material). In contrast,
LTD inhibition was observed in DN-
RAGE slices treated with A (Fig. 3F).
Thus, microglial RAGE activation by 1 M
A is relevant to induce synaptic depres-
sion and LTD impairment.
A-dependent synaptic depression
and LTD inhibition is mimicked by
IL-1 and prevented by IL-1
receptor antagonist
So far, our data showed that micromolar
A(1-42) activates RAGE in microglia
leading to synaptic dysfunction. The next
step was to investigate the factors and
mechanisms linking microglial activa-
tion by A/RAGE signaling to synaptic
dysfunction. Microglial RAGE has been
implicated in the development of inflam-
matory response and cellular dysfunction
(Lue et al., 2001; Bianchi et al., 2010). Cy-
tokines, in particular IL-1 and TNF-,
released by microglial cells, are key mole-
cules that are capable of modulating syn-
aptic function and plasticity (Coogan et
al., 1999; Ikegaya et al., 2003; Kelly et al.,
2003; Pickering et al., 2005). To test the
possible involvement of cytokines, we first
tried to mimic A-dependent synaptic
depression by exogenously applying
IL-1 (1 ng/ml) and TNF- (5 ng/ml) on
slices for 10 min. We found (Fig. 4A) that
IL-1, but not TNF-, was able to signif-
icantly depress basal synaptic transmis-
sion (83  5%, n  5, p  0.05 vs baseline, and 98  4%, n  5,
p  0.05 vs baseline, respectively). Differently to what observed in
A-treated slices, IL-1-induced depression was persistent and
FP amplitude did not return to baseline values after the washout
(Fig. 4A). This result is consistent with the previous finding in the
hippocampus, showing a similar degree of persistent depression
after bath application of IL-1; induction and maintenance
phases of synaptic depression are differently modulated by GABA
receptor activation with a GABA receptor-independent acute
phase and a GABA receptor-dependent, maintenance phase sen-
sitive to GABAA receptor block (Ikegaya et al., 2003). To investi-
gate whether the different kinetics of synaptic depression
Figure 1. A (1 M) causes synaptic depression and LTD impairment in entorhinal cortex. A, Acute application of 1 M
A(1-42) for 10 min (corresponding to dark bar) induced a depression of FP amplitude (gray circles), whereas no change in FP
amplitude was observed in vehicle-treated slices (white circle) and in control slices treated with the reverse sequence peptide
A(42-1) at 1 M for 10 min (black circles); the insets represent typical traces of FPs recordings before (thick line) and during A
perfusion. B, LFS (900 paired pulses at 1 Hz, 30 ms interstimulus interval) was able to induce LTD in control vehicle-treated slices,
but failed to do so in slices treated with 50 M AP5; the insets represent typical traces of FPs recordings before and after LFS in
vehicle- or AP5-treated slices. C, Bath perfusion with 1 M A before LFS stimulation induced a significant depression of FP
amplitude that inhibits LFS-induced LTD; indeed, the magnitude of FPs after LFS was unchanged. D, LTD was blocked by prolonged
perfusion (40 min) with A (1 M) and simultaneous LFS application. E, Acute application for 10 min (dark bar) of A (1 M)
induced a depression of FP amplitude that recovers to the baseline after washout; LTD was normally expressed when LFS was
applied after A washout. F, A (10 min perfusion)-induced depression was not occluded by LFS. Calibration: A, B, horizontal, 5
ms; vertical, 0.5 mV. Error bars indicate SEM.
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between A and IL-1 might reflect a different sensitivity to
GABAergic drugs, we used the GABAA receptor antagonist bicu-
culline. A synaptic depression was not modified by bicuculline
(supplemental Fig. S2B, available at www.jneurosci.org as sup-
plemental material). Moreover, IL-1 perfusion before LFS in-
hibited LTD in EC slices (Fig. 4B), similarly to what was observed
with 1 M A and according to what has been previously shown
in the hippocampus (Ikegaya et al., 2003). In contrast, LTD was
normally expressed in slices treated with TNF- (supplemental
Fig. S2C, available at www.jneurosci.org as supplemental mate-
rial). To determine a direct effect of IL-1 on A-induced syn-
aptic depression, we perfused the slices with 1 M A(1-42) in the
presence of IL-1Ra, the interleukin-1 receptor antagonist. As re-
ported in Figure 4C, when slices were treated with IL-1Ra (20
ng/ml), 1 M A failed to induce synaptic depression (mean FP
amplitude was 98  3%; n  6; p  0.05 vs baseline). In addition,
treating the slices with IL-1Ra prevented LTD inhibition after A
exposure; the mean LTD under this condition (74  4%; n  5)
(Fig. 4D) was comparable with LTD recorded in vehicle-treated
slices (Fig. 1B). Thus, IL-1 contributes to 1 M A effects on
synaptic function. We next investigated whether A/RAGE inter-
action induces an increase of IL-1 level in EC slices. Using an
ELISA (Fig. 4E), we found that IL-1 level was significantly in-
creased in EC slices exposed to 1 M A for 10 min (39.7  0.7
pg/ml vs 17.4  1.4 pg/ml in control slices; n  6; p  0.05).
Deficiency of RAGE signaling in microglia (DNMSR slices) and
RAGE blockade by anti-RAGE IgG were not able to modify basal
IL-1 levels (16.8  4.6 and 19.2  2.8 pg/ml, respectively; n  6;
p  0.05 vs control). More importantly, RAGE blockade by anti-
RAGE IgG and deficiency of RAGE signaling in microglia com-
pletely prevented 1 M A effect, maintaining IL-1 levels
comparable with basal values (21.7  2.5 and 19.4  1.8 pg/ml,
respectively; n  6; p  0.05 vs control, p  0.05 vs A alone). We
also measured TNF- level in the same experimental condition
without finding any significant increase after A treatment (sup-
plemental Fig. S2D, available at www.jneurosci.org as supple-
mental material). Interestingly, low concentrations of A (250
and 500 nM) (Fig. 4F) did not produce any increase in IL-1 with
respect to vehicle-treated slices. Moreover, a higher concentra-
tion of A (2 M) was unable to induce additional increase of
IL-1 levels with respect to results obtained with 1 M A (Fig.
4F). Thus, A mediated the induction of IL-1 in EC slices at
concentration and application times comparable with those used
to induce synaptic depression and LTD inhibition.
A-induced synaptic depression and LTD inhibition is
prevented by inhibition of JNK and p38 MAPK
Stress-related protein kinases, such as JNK and p38 MAPK, are
activated in several pathologic processes, including AD neurode-
generation and A cytotoxicity (Pei et al., 2001; Troy et al., 2001;
Zhu et al., 2005). It is noteworthy that both JNK and p38 MAPK
inhibition prevented A-induced LTP impairment in hippocam-
pal (Wang et al., 2004) and EC slices (Origlia et al., 2008). In
particular, we demonstrated that 200 nM A(1-42) interacting
with neuronal RAGE induced impairment of LTP through acti-
vation of p38 MAPK signaling cascades (Origlia et al., 2008). To
determine whether micromolar A (1 M) affects synaptic func-
tion through the stress-activated signaling cascades, we used dif-
ferent inhibitors of kinases. In particular, we used a JNK inhibitor
(SP600125) and a p38 MAPK inhibitor (SB203580) to prevent
A-induced synaptic depression (Lali et al., 2000; Bennett et al.,
2001). Perfusion with either compound did not induce signifi-
cant change in extracellular FP amplitude during baseline record-
Figure 2. A (1 M) affects mEPSC amplitude and depresses AMPA-mediated synaptic
transmission. A, mEPSCs recorded in the presence of TTX (1 M) and bicuculline (3 M);
examples of traces recorded before, during, and after perfusion with 1 M A(1-42).
Calibration: horizontal, 10 s; vertical, 20 pA. B, The plot represents average mEPSC ampli-
tude recorded in control condition (vehicle), during 10 min perfusion with 1 M A, and
after A washout. mEPSC amplitude was significantly decreased (*p  0.05) during A
perfusion; after washing out A, the amplitude of mEPSCs returned to control values. C,
Ten minute perfusion with 1 M A had no effect on the frequency of mEPSC; plot
represents average frequency of mEPSCs recorded in control condition (vehicle), during 1
M A perfusion, and after A washout. D, Traces represent examples of evoked EPSCs
that were recorded at 70 and 50 mV, respectively, in control (vehicle) and after 1 M
A perfusion. The amplitude of AMPA EPSC component was measured at 70 mV,
whereas NMDA EPSC component was calculated at 50 mV, 50 ms after the AMPA peak
(see dashed lines). The gray traces represent recordings at 50 mV, where the AMPA
component was isolated using AP5 (50 M). Calibration: horizontal, 50 ms; vertical, 50 pA.
E, Perfusion with 1 M A caused a significant reduction of AMPA-mediated EPSC peak
amplitude; in the top panel, the plot represents averaged relative amplitude of AMPA
EPSCs recorded at 70 mV in control condition (vehicle), during 10 min of 1 M A
perfusion, and after A washout (*p  0.01). In the bottom panel, a complete I–V curve
is reported for AMPA EPSCs recorded in control (vehicle), during A perfusion. F, A did
not significantly affect NMDA currents; in the top panel, the plot represents averaged
relative amplitude of NMDA EPSCs recorded at 50 mV in control condition (vehicle),
during 10 min of 1 M A perfusion, and after A washout (*p  0.01). In the bottom
panel, a complete I–V curve is reported for NMDA EPSCs recorded in control (vehicle)
conditions and under A perfusion. Error bars indicate SEM.
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ings in EC slices in agreement with what has been previously
reported (Origlia et al., 2008). When slices were continuously
perfused with 1 M SB203580 or 20 M SP600125 (Fig. 5A), 10
min application of 1 M A(1-42) was unable to cause synaptic
depression (100  3%, n  6, and 102  4%, n  6, respectively;
p  0.05 vs baseline; p  0.05 vs 83  2%; n  11 in slices treated
with A alone). This suggests that synaptic depression elicited by
A is dependent on the activation of either JNK or p38 MAPK.
However, these two kinases are differently involved in EC LTD
expression (Fig. 5B), for instance, LTD was completely abolished
by p38 MAPK inhibition using SB203580 (104  5%; n  6; p 
0.05 vs baseline), whereas LTD was unaffected when slices were
perfused with the JNK inhibitor (SP600125; 74  8%; n  7; p 
0.05 vs baseline; p  0.05 vs control) (Fig. 1B). This result indi-
cates that p38 MAPK, but not JNK, is required for LTD expres-
sion in the EC, which is in agreement with
previous studies showing a role for
p38MAK activation in both metabotropic
glutamate receptor (mGluR)-dependent
and NMDA-dependent LTD in the hip-
pocampus (Bolshakov et al., 2000; Rush et
al., 2002; Zhu et al., 2002; Huang et al.,
2004; Hsieh et al., 2006) and neocortex
(Xiong et al., 2006). Next, we examined
the effect of JNK that is not involved in
physiological mechanisms underlying
LFS-LTD with the aim of preventing
A-dependent LTD inhibition. Using
SP600125, we rescued LTD elicited by
LFS in EC slices exposed to 1 M A (Fig.
5C) (mean LTD was 73  9%; n  6; p 
0.05 vs baseline). Our results suggest that
p38 MAPK and JNK are important key
events in A-dependent synaptic depres-
sion and LTD impairment.
A increases p38 MAPK and JNK
phosphorylation in cortical slices
To further investigate the effect of RAGE-
dependent activation of p38 MAPK and
JNK on A-mediated neuronal dysfunc-
tion, we measured the levels of phosphor-
ylated p38 MAPK and phosphorylated
JNK in EC slices that were collected after
the end of electrophysiological experi-
ments. When slices were analyzed after 10
min perfusion with 1 M A(1-42), we
found an increase of p38 MAPK phos-
phorylation (Fig. 6A). Tissue level of
phospho-p38 MAPK in the presence of
A was significantly higher than that in
control vehicle-treated slices (21.6  7.9
vs 5.2  1.52 U/ng; n  6; p  0.05). Se-
lective deficiency of RAGE signaling in
microglia (DNMSR) or complete inacti-
vation of RAGE (anti-RAGE IgG) did not
modify the basal level of phospho-p38
MAPK (3.9  0.2 and 5.5  2 U/ng, re-
spectively; n  6; p  0.05 vs control ve-
hicle). However, slices either from
DNMSR mice or WT mice treated with
anti-RAGE IgG displayed complete sup-
pression of phospho-p38 MAPK in the
presence of A (3  1.3 and 2.4  0.7 U/ng in DNMSR and
anti-RAGE IgG-treated slices, respectively; n  6; p  0.05 vs
slices treated with A alone). These data indicate the contribu-
tion of microglial RAGE signaling to the A-involved activation
of p38 signal pathway. To further examine the effect of IL-1 on
A-induced activation of p38 MAPK, slices were treated with
IL-1Ra plus A. Addition of IL-1Ra in the presence of A signif-
icantly reduced levels of phopho-p38 (7.6  0.5 U/ng; n  6; p 
0.05 vs A alone), suggesting the involvement of IL-1 in A-
mediated activation of p38 pathway.
Consistent with the aforementioned results showing that p38
MAPK activation is required for LTD, we found that the level of
p38 MAPK phosphorylation (Fig. 6A) was significantly increased
after LFS with respect to control condition without stimulation
(19.2  5.1 U/ng in vehicle plus LFS; n  6; p  0.05 vs vehicle
Figure 3. Microglial RAGE contributes to A-induced synaptic depression and LTD impairment. A, Blockade of RAGE by either
knocking out RAGE gene or with neutralizing anti-RAGE IgG was able to prevent A depression; FP amplitude in RAGE-null (black
circles) and anti-RAGE IgG (white circles)-treated slices did not significantly change during 10 min 1 M A(1-42) perfusion (dark
bar) and was significantly different from FP amplitude in WT slices treated with A alone (gray circles). B, RAGE-deficient signaling
in neurons (DN-RAGE, white circles) was not sufficient to prevent 1 M A-induced synaptic depression; in contrast, A failed to
induce synaptic depression in DNMSR slices characterized by RAGE signaling deficiency in microglia (black squares). After 1 M A
treatment (dark bar), LTD was not impaired and normally expressed in anti-RAGE IgG-treated (C, white squares), RAGE-null (D,
black circles), and DNMSR slices (E, dark squares). F, In contrast, LTD impairment was observed in DN-RAGE slices treated with A.
The insets in A and B represent typical traces of FPs recordings before (dark line) and during (gray line) A perfusion. Calibration:
horizontal, 5 ms; vertical, 0.5 mV. Error bars indicate SEM.
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without LFS). We observed a similar in-
crease after LFS when RAGE signaling was
blocked (19.8  8 U/ng in anti-RAGE
IgG-treated slices and 21.7  8 U/ng in
DNMSR slices; n  6 in each group; p 
0.05 vs vehicle without LFS). Interest-
ingly, LFS-induced p38 MAPK activation
was enhanced after 10 min of 1 M A
perfusion with respect to vehicle-treated
LFS stimulated slices (42.5  11 U/ng; n 
6; p  0.05 vs vehicle, anti-RAGE IgG, and
DNMSR after LFS stimulation). Similarly,
RAGE blockade, deficiency of RAGE sig-
naling in microglia, and treatment with
IL-1Ra reduced significantly A-induced
p38 MAPK activation after LFS (24.7  4,
17.8  7.6, 19.4  11.6 U/ng; n  6 each
group; p  0.05 vs A plus LFS), even if a
significant increase was still observed with
respect to basal condition (vehicle-treated
slices without LFS), which was consistent
with a rescue of a normal LTD as shown in
Figures 3C–E and 4D.
Similarly, we measured JNK phos-
phorylation levels in EC slices after A ex-
posure and in the absence of LFS (Fig.
6B). Slice perfusion with 1 M A for 10
min significantly increased the JNK phos-
phorylation compared with the vehicle-
treated slices (141.9  25.3 vs 73.8  2.9
U/ng; n  6; p  0.05). As reported for
p38 MAPK, A effect on JNK was com-
pletely prevented by RAGE blockade and
deficiency of RAGE signaling in microglia
(94.5  10 U/ng in anti-RAGE IgG plus
A and 77.7  19 U/ng in DNMSR plus
A; n  6; p  0.05 vs A alone) and
IL-1Ra pretreatment (93  8.7 U/ng; n 
6; p  0.05 vs A alone). Since JNK acti-
vation is not required for LTD expression
as shown in Figure 5B, JNK phosphoryla-
tion was not significantly increased in
vehicle-treated slices after LFS (90.3  9.3
U/ng; n  6; p  0.05 vs vehicle without
LFS). Similar results (Fig. 6B) were ob-
tained in slices pretreated with anti-RAGE
IgG and in DNMSR slices after LFS
(67.8  13 and 89.6  5.3 U/ng, respec-
tively; n  6 each group; p  0.05 vs vehi-
cle). Thus, LFS per se did not change JNK
phosphorylation. In contrast, in A-
treated slices, JNK was persistently acti-
vated even after LFS (175.9  11.6 U/ng;
n  6; p  0.05 vs vehicle plus LFS), as an
abnormal effect induced by A(1-42). More importantly, JNK
phosphorylation after A exposure and LFS was significantly re-
duced in anti-RAGE IgG-treated slices, DNMSR slices and IL-
1Ra-treated slices with respect to slices exposed to A alone (Fig.
6B) (94.5  10, 105  13, 94  9 U/ng, respectively; n  6 each
group; p  0.05 vs A plus LFS). Thus, levels measured by ELISA
show that p38 MAPK and JNK are both hyperphosphorylated in
slices exposed to 1 M A(1-42) under the control of microglial
RAGE. We further examined JNK and p38 MAPK signaling
pathways by using specific inhibitors of their phosphorylation.
Interestingly, the JNK inhibitor SP600125 significantly reduced
p38 MAPK phosphorylation in A-exposed slices either before
(Fig. 6A) (4.6  1.5 U/ng; p  0.05 vs A alone) or after LFS
(16.2  4.5 U/ng; p  0.05 vs A plus LFS). In contrast, p38
MAPK inhibition with SB203580 was not able to prevent A
induced activation of JNK (Fig. 6B). The most plausible interpre-
tation of these results is that A/RAGE signaling induces an in-
crease in JNK phosphorylation that controls p38 MAPK and
Figure 4. A-induced depression and LTD impairment is partially mimicked by IL-1 and prevented by IL-1 receptor antag-
onist. A, IL-1 (1 ng/ml; gray circles) treatment for 10 min (dark bar), but not TNF- (5 ng/ml; white circles), was able to
significantly depress basal synaptic transmission. B, IL-1 (1 ng/ml) perfusion for 10 min (dark bar) before LFS impaired LTD. C, D,
When slices were treated with 20 ng/ml IL-1Ra, 1 M A (dark bar) failed to induce synaptic depression of FP amplitude (C, black
circles) and prevented LTD impairment (D, black circles). The insets in A and C represent typical traces of FPs recordings before (dark
line) and during (gray line) A perfusion. Calibration: horizontal, 5 ms; vertical, 0.5 mV. E, The plot represents average IL-1 levels
(in picograms per milliliter) in EC slices; IL-1 level was significantly increased in cortical slices exposed to 1 M A for 10 min,
whereas deficiency of RAGE signaling in microglia (DNMSR slices) or complete RAGE inactivation by anti-RAGE IgG (2.5 g/ml) did
not modify basal IL-1 levels but prevented A effect maintaining IL-1 levels comparable with control values ( p  0.05 vs
control). Serum samples were used as positive control provided with the kit. F, The plot represents IL-1 levels in EC slices exposed
to increasing A concentrations; as reported in E, 1 M A elevated IL-1 levels, whereas lower concentrations (250 and 500 nM)
of A did not produce any increase in IL-1 with respect to control slices; moreover, increase of A concentration up to 2 M did
not induce significantly higher IL-1 levels with respect to those measured in 1 M-treated slices [*p  0.05 vs vehicle-treated
slices (0), 250 and 500 nM]. Error bars indicate SEM.
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IL-1 levels. Indeed, ELISA revealed that blockade of JNK
(SP600125; 19.3  4.5 pg/ml in SP600125 plus A vs 39.7  6.9 in
A alone; p  0.05) but not p38 MAPK (SB203580; 38.8  5.3
pg/ml in SB203580 plus A vs 39.7  6.9 in A alone; p  0.05)
was able to significantly reduce IL-1 levels in slices exposed to
A (Fig. 6C).
Discussion
Oligomeric A plays an important role in the development of
neuronal impairment leading to cognitive deficits. Recent results
showed that oligomeric soluble A was able to induce an impair-
ment of synaptic function in the hippocampus (for review, see
Selkoe, 2002) and EC (Origlia et al., 2008), two vulnerable areas
in AD (Braak and Braak, 1991) that play a crucial role in learning
and memory (Witter et al., 1989; Braak et al., 1993; Suzuki and
Amaral, 2004). In particular, human natural oligomers and syn-
thetic oligomeric A at low concentrations were capable of
acutely inhibiting LTP (Lambert et al., 1998; Chen et al., 2002;
Vitolo et al., 2002; Walsh et al., 2002, 2005; Wang et al., 2004;
Zhao et al., 2004). Finally, several reports showed that adminis-
tration of A at higher concentrations than those inducing pure
inhibitory effect on LTP (Origlia et al., 2008, 2009) depressed
synaptic transmission and impaired a second form of long-term
synaptic plasticity, namely the LTD, by increasing the synaptic
removal of glutamate receptors (Snyder et al., 2005; Tyszkiewicz
and Yan, 2005; Hsieh et al., 2006; Parameshwaran et al., 2007).
Here, we demonstrated for the first time in the EC that a micromolar
concentration of synthetic A oligomers induces a depression of
synaptic transmission and an impairment of NMDA-dependent
form of LTD induced by LFS. We interpreted this result as sug-
Figure 5. A-induced depression and LTD impairment is prevented by inhibition of JNK and
p38 MAPK. A, Treatment of slices with 1 M SB203580 and 20 M SP600125 (black diamond
and white circles, respectively); application of 1 M A(1-42) for 10 min (dark bar) was unable
to induce synaptic depression. B, LFS-induced LTD was completely abolished by p38 MAPK
inhibition with SB203580 (1 M; gray squares) but was normally expressed in slices after JNK
inhibition with SP600125 (20 M; gray circles). C, SP600125 treatment rescued a normal LTD in
slices after 1 M A exposure (for 10 min; dark bar). Error bars indicate SEM.
Figure 6. A (1 M) increases p38 MAPK/JNK phosphorylation in cortical slices. A, The plot
represents averaged phospho-p38 MAPK levels measured using ELISA and expressed as unit/
total content of p38 MAPK protein. Tissue levels of phospho-p38 MAPK after slices perfusion
with 1 M A(1-42) were significantly higher with respect to control vehicle-treated slices
(*p  0.05 vs control vehicle) both before and after LFS. Selective deficiency of RAGE signaling
in microglia (DNMSR) and complete inactivation of RAGE with anti-RAGE IgG did not modify
basal level of phospho-p38 MAPK ( p  0.05 vs control vehicle). Blockade of RAGE was able to
prevent A-induced increase of phospho-p38 MAPK ( p  0.05 vs slices treated with A
alone), even if the increase induced by LFS was still present. p38 MAPK activation by A was
also significantly reduced in slices treated with IL-1Ra ( p  0.05 vs A alone) and in slices
treated with the JNK inhibitor SP600125 ( p  0.05 vs A alone). B, The plot represents
averaged phospho-JNK levels measured using ELISA and expressed as unit/total content of JNK
protein. Elevated phospho-JNK levels were increased by 1 M A treatment (*p  0.05 vs
control vehicle) but not by LFS. Deficiency of RAGE signaling in microglia (DNMSR) and complete
inactivation of RAGE with anti-RAGE IgG did not modify basal level of phospho-JNK both before
and after LFS ( p  0.05 vs control vehicle). Blockade of RAGE was able to prevent A-induced
increase of phospho-JNK ( p  0.05 vs slices treated with A alone). Phospho-JNK level after 1
M A treatment was also significantly reduced in slices treated with IL-1Ra ( p  0.05 vs A
alone). C, The plot represents average IL-1 levels (in picograms per milliliter) in EC slices; IL-1
level was significantly increased in cortical slices exposed to 1 M A for 10 min, whereas
inhibition of JNK (SP600125) but not of p38 MAPK (SB203580) prevented A effect and IL-1
levels were comparable with control values ( p  0.05 vs control). Error bars indicate SEM.
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gesting that transient synaptic depression and disruption of LFS-
LTD by A are governed by distinct synaptic mechanisms.
Although we cannot completely rule out the possibility that pre-
vious synaptic depression interacts with LFS-LTD in the presence
of A (when the two synaptic events are sequentially evoked as in
our experimental conditions), we are confident that transient
synaptic depression does not depend on LFS-LTD-related mech-
anism; indeed, we showed that previous induction of LFS-LTD
does not occlude additional synaptic depression by A.
Remarkably, A concurred to reduction of AMPA receptor
function, according to previous studies supporting the involve-
ment of this subtype of glutamate receptors on A-dependent
synaptic dysfunction (Hsieh et al., 2006; Parameshwaran et al.,
2007). However, other reports showed that a second type of glu-
tamate receptors, namely the NMDA receptor, is implicated in
A-dependent impairment of synaptic transmission (Kim et al.,
2001; Snyder et al., 2005; Tyszkiewicz and Yan, 2005). A recent
report in the hippocampus showed that oligomeric A facilitates
LTD induction interfering with NMDA and mGlu receptors (Li
et al., 2009). Consistent with the report by Li et al. (2009) showing
no significant change in the magnitude of NMDA receptor-
dependent LTD after A treatment, in a previous paper from our
laboratories (Origlia et al., 2008), we reported that synthetic
A(1-42) in the nanomolar range inhibits LTP leaving normal
LTD. Thus, the present and previous reports suggest that oligo-
meric A plays an important role in the progressive alteration of
different synaptic functions and raise the important issue of iden-
tifying receptor(s) and signal transduction pathways responsible
for neuronal impairment in AD.
We focused our study on RAGE-dependent signaling in neu-
ronal and non-neuronal cells insulted by A (Yan et al., 1995;
Hofmann et al., 1999; Lue et al., 2001; Schmidt et al., 2001; Deane
et al., 2003; Lue et al., 2005). Previous reports showed that RAGE
is implicated in disruption of synaptic function by oligomeric A
(Arancio et al., 2004; Origlia et al., 2008). In particular, the find-
ing that nanomolar oligomeric A inhibits LTP through activa-
tion of RAGE in neurons (Origlia et al., 2008) prompted us to
investigate whether cell-specific activation of RAGE by micromo-
lar A is involved in synaptic depression and LTD impairment.
We provided evidence that blockade of RAGE signaling in micro-
glial cells, but not in neurons, is capable of preventing A-
dependent impairment of synaptic transmission and LTD
inhibition. In addition, microglial RAGE plays a key role in the
development of inflammatory response and cellular dysfunction
in an A milieu (Du Yan et al., 1997; Lue et al., 2001; Fang et al.,
2010). This raises the important issue of identifying factors and
mechanisms released by microglial cells on exposition to A that
are capable of interacting with neurons. Activated microglial cells
produce a wide spectrum of proinflammatory and cytotoxic fac-
tors, including TNF- and IL-1 (for review, see Simm et al.,
2004), two cytokines implicated in AD pathogenetic mechanisms
(Akiyama et al., 2000). Importantly, IL-1 is implicated in dis-
ruption of synaptic efficacy induced by proinflammatory agents
(Curran et al., 2003; Kelly et al., 2003). Moreover, in the hip-
pocampus, IL-1 induced synaptic depression, inhibiting the
subsequent induction of LTD in response to a 1 Hz electrical
stimulation (Ikegaya et al., 2003). According to this, our data
showed that IL-1, but not TNF- is able to induce synaptic
depression and LTD inhibition in EC, partially mimicking A
action. Notably, blocking IL-1 receptor by the addition of IL-
1Ra completely abolished A effect on synaptic transmission and
prevented LTD impairment. Consistent with this observation,
A, at micromolar but not at nanomolar concentrations, was
able to increase IL-1 levels in EC slices. An important new find-
ing was that functional inactivation of RAGE or deficiency of
RAGE signaling in microglia significantly suppresses A-induced
IL-1 production. We propose that A/RAGE signaling in mi-
croglial cells leads to release of IL-1 that binds IL-1 receptor in
neurons, causing synaptic depression and LTD impairment.
Therefore, we consider IL-1 as a good candidate to link micro-
glial RAGE activation to neuronal dysfunction in inflammatory
process accompanying the accumulation of A in AD.
With regard to the intracellular signaling cascade(s) activated
by A–RAGE interaction, this/these include pathways such as
p21ras, extracellular signal-regulated kinase 1/2 (p44/p42) MAP-
kinases, p38 MAPK, and SAPK (stress-activated protein kinase)/
JNK, Rho GTPases, phosphoinositol-3 kinase, and the JAK/STAT
(signal transducer and activator of transcription) pathway. Acti-
vation of different protein kinase cascades is the principal target
of RAGE activation in cell pathway controlling synaptic plastic-
ity. In particular, we considered two different kinases, namely
JNK and p38 MAPK, as potentially involved in synaptic dysfunc-
tion induced by oligomeric micromolar A. Our recent report
showed that nanomolar A was able to phosphorylate p38 MAPK
in cultured cortical neurons at concentrations and incubation
time comparable with those used for LTP inhibition (Origlia et
al., 2008; Takuma et al., 2009). In the present paper, we reported
that p38 MAPK phosphorylation is required for LTD in EC, in
agreement with previous reports (Bolshakov et al., 2000; Rush et
al., 2002; Huang et al., 2004; Xiong et al., 2006). Furthermore, we
showed that p38 MAPK phosphorylation is also required for LTD
impairment. Notably, A exposure increased phosphorylated
levels of p38 MAPK, which were further enhanced after LFS, an
electrical stimulation capable of phosphorylating p38 MAPK
during LTD. Importantly, RAGE inactivation in microglia and
blockade of IL-1 signaling prevented A induced p38 MAPK
activation.
The other major stress-related kinase, JNK, was associated
with IL-1-induced inhibition of LTP in hippocampus (Curran
et al., 2003) and mGluR-dependent LTD as shown by using JNK1
knock-out mice (Li et al., 2007). In addition, bulk of results indi-
cated that high A level is able to induce phosphorylation of JNK
(Shoji et al., 2000; Morishima et al., 2001; Troy et al., 2001; Jang
and Surh, 2002; Wei et al., 2002; Fogarty et al., 2003; Minogue et
al., 2003). Differently to what demonstrated for p38 MAPK, JNK
activation is not required for LTD in EC, since the specific inhib-
itor SP600125 did not affect this form of synaptic plasticity. How-
ever, abnormal JNK activation is an important step leading to
A-induced synaptic depression and LTD impairment. Indeed,
both synaptic depression and LTD impairment were prevented
by SP600125. Remarkably, phosphorylated-JNK levels were in-
creased in slices on micromolar A exposure, an effect that was
blocked by interfering with microglial RAGE and IL-1 signaling.
Consistent with our data, a previous report showed that RAGE
activation in neuronal and non-neuronal cells by different li-
gands was able to induce JNK phosphorylation (Chang et al.,
2008; Bianchi et al., 2010). Finally, we showed that inhibition of
JNK prevented A-dependent phosphorylation p38 MAPK and
IL-1 increase, whereas the specific inhibition of p38 MAPK left
JNK and IL-1 unaffected on exposure to A. Together, our
results suggest that p38 MAPK and JNK activation are important
key events in A-mediated synaptic depression and LTD impair-
ment. We interpreted our results as suggesting that micromolar
oligomeric A activates JNK by interacting with microglial
RAGE. The kinase, in turn, controls the release of proinflamma-
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tory cytokines, such as IL-1, which may affect synaptic function
through neuronal overactivation of p38 MAPK.
The present study also suggests that additional mechanisms
may underlie synaptic dysfunction induced by A behind LTP
inhibition through activation of MAPK cascade (Wang et al.,
2004; Origlia et al., 2008). We want to remark that, in animal
models of AD characterized by progressive accumulation of A,
LTP disruption occurs before deficits in basal synaptic transmis-
sion (Trinchese et al., 2004; Chang et al., 2006) and LTD (Chang
et al., 2006). The nanomolar concentration of synthetic A(1-42)
inhibits LTP through activation of RAGE in neurons and phos-
phorylation of p38 MAPK (Arancio et al., 2004; Origlia et al.,
2008). However, increasing A concentration up to 1 M induces
specific phosphorylation of p38 MAPK and JNK in neuronal and
non-neuronal cells that depend on microglial RAGE activation
along with the induction of proinflammatory cytokine, such as
IL-1. IL-1 would consequently affect basal synaptic transmis-
sion and LTD. Together, our previous and present results sup-
port the concept that impaired LTP characterizes an early stage in
AD progression corresponding to a low A load; later stages in
AD progression are associated with a greater A load that exag-
gerates impairments in basal synaptic transmission and LTD.
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